Editing PHKG Business Models & Market (section)

=== 2. Health Data Intermediary Platform ===
'''What:''' Platform enabling patients to control, curate, and share their health data. Regulated under EU Data Governance Act.

'''Who does this today:'''
* [[MIDATA Cooperative]] — Swiss data cooperative, patient-owned health data
* [[Egnosis]] — Romanian health data intermediary
* MIDATA model: patients store data, consent to sharing, receive value
* Solid Project (Tim Berners-Lee) — personal data pods

'''Revenue model:'''
* B2B: Hospitals pay for patient data access for research (anonymized)
* B2B2C: Pharmaceutical companies pay for curated patient cohorts
* Platform fees: % of data sharing transactions
* Subscription: patients pay for data management

'''Value:''' By 2030, EU citizens will control their data (EHDS vision). Intermediaries facilitate this. Market for consent management alone is growing rapidly.<ref>Nature (2025): "A user-driven consent platform for health data sharing in digital health applications" — https://www.nature.com</ref>

'''Regulatory tailwind:''' EU Data Governance Act (2022), EHDS regulation (2024), EU AI Act — all require trustworthy data intermediaries.